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Since antiquity, Achillea millefolium L. (Asteraceae) has 
been used in traditional medicine of several cultures, 
from Europe to Asia. Its richness in bioactive compounds 
contributes to a wide range of medicinal properties. In 
this study, we assessed A. millefolium methanolic extract 
and its isolated components for free radical scaveng-
ing activity against 2,2-diphenyl-pycrilhydrazyl, total 
antioxidant capacity (based on the reduction of Cu++ to 
Cu+), and ability to inhibit lipid peroxidation. The activity 
against chloroquine-sensitive and chloroquine-resistant 
strains of Plasmodium falciparum was also tested. Chlo-
rogenic acid, its derivatives and some flavonoids isolat-
ed by semipreparative HPLC and identified by NMR and 
spectrometric techniques were the major bioactive con-
stituents of the methanolic extract. The latter exhibited 
significant antioxidant properties, as well as its flavonol 
glycosides and chlorogenic acids. With regard to the an-
tiplasmodial activity, apigenin 7-glucoside was the most 
effective compound, followed by luteolin 7-glucoside, 
whereas chlorogenic acids were completely inactive. On 
the whole, our results confirmed A. millefolium as an 
important source of bioactive metabolites, justifying its 
pharmaceutical and ethnobotanical use.
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INTRODUCTION
Achillea millefolium L. (Asteraceae) grows wild all around 
Europe, Asia, North Africa and North America and it is 
widely used in Italian folk medicine (Pieroni & Quave, 
2005; Passalacqua et al., 2007; Vitalini et al., 2009). Its 
properties have been known since antiquity and its use is 
diffused in many cultures from Europe to Asia: in Greece, 
in the region of Thessaloniki, for instance, A. millefolium 
is recommended for the treatment of many different ail-
ments (Kokkini et al., 2004); in West Azerbaijan, Iran, the 
infusion of dried flowers is considered suitable for the 
treatment of hemorrhoids, dyspepsia, dysmenorrhoea and 
gastritis (Miraldi et al., 2001); in the Parvati valley, west 
Himalaya, India, leaves and flowers are used for gastric 
problems and fever (Sharma et al., 2004). 
Since 1975, several studies on the phytochemical com-
position of A. millefolium have been reported and led to 
the identification of flavonoids and caffeic acid deriva-
tives (Falk et al., 1975; Guédon et al., 1993; Glasl et al., 
2002; Benedek et al., 2007; Innocenti et al., 2007). All 
these studies increased the knowledge on the chemi-
cal composition of this species but, to date, a complete 
characteristicts of its phenolic compounds is not yet 
available. 
Concerning the bioactivity of this plant, recent studies 
reported antimicrobial, antiphlogistic, hepatoprotective, 
antispasmodic and calcium antagonist activities of its po-
lar extracts (Stojanović et al., 2005; Yaeesh et al., 2006), 
and a protective effect of its infusions against H2O2-
induced oxidative damage in human erythrocytes and 
leucocytes (Konyalioglu & Karamenderes, 2005). Some 
articles have described antimalarial activity of flavonoids 
from plant sources (Schwikkard & van Heerden, 2002; 
Saxena et al., 2003; Lehane & Saliba, 2008; Kaur et al., 
2009) and, particularly, Murnigsih and colleagues (2005) 
screened the activity of water extract of A. millefolium 
against Plasmodium falciparum with positive results, stimu-
lating our interest to study the activity of methanolic ex-
tract from A. millefolium and of its pure compounds.
Hence, the first aim of the present work was to 
achieve a comprehensive characterization of phenolic bi-
oactive compounds present in this species; subsequently, 
the crude extract and pure compounds were tested in 
different models for antioxidant and antiplasmodial ac-
tivities.
MATERIALS AND METHODS
Chemicals. Ascorbic acid (99 %), chlorogenic acid 
(95 %), gallic acid (98 %) and quercetin (98%) were from 
Sigma-Aldrich (Milan, Italy). The organic solvents were 
all of analytical grade (Sigma-Aldrich, Milan, Italy). Deu-
terated dimethylsulphoxide (dmso-d6) was from Sigma-
Aldrich (Milan, Italy).
*e-mail: marcello.iriti@unimi.it
Abbreviations: CQ, chloroquine; DCQA, dicaffeoyl-quinic acid; 
DPPH, 2,2-diphenyl-picrylhydrazyl; ESI-MS/MS, electrospray ioniza-
tion tandem mass spectrometry; HPLC, high performance liquid 
chromatography; IC50, 50 % inhibitory concentration; LDL, low den-
sity lipoproteins; m, molecular mass; NMR, nuclear magnetic reso-
nance; PBS, phosphate buffered saline; RP, reverse phase; Rt, reten-
tion time; S.D., standard deviation; TAC, total antioxidant capacity; 
TBARS, thiobarbituric acid-reactive substance; TLC, thin layer chro-
matography; TMS, tetramethylsilane; tR, relative retention time
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Plant material. The aerial parts of A. millefolium were 
collected during summer 2007, in Oro di Morondo, Var-
allo Sesia (700 m) (Vercelli, Italy). A voucher specimen 
(no. Am 310) has been deposited in the Department of 
Biology of Milan University after their identification by 
an expert local botanist (Dr. Gianfranco Rotti), accord-
ing to “Flora d’Italia” (Pignatti, 1982).
Extraction, isolation and identification. Air-dried, 
powdered aerial parts of A. millefolium (112 g) were ex-
tracted exhaustively with n-hexane, CHCl3, CHCl3/
MeOH (9:1, v/v) and MeOH in a Soxhlet apparatus. 
MeOH extract (4.5 g) was chromatographed on Sepha-
dex LH-20 (Pharmacia, 100 × 2.5 cm, flow rate 3.0 mL/
min) using MeOH as eluent, giving 254 fractions of 3 
mL, combined together into 20 subfractions according 
to TLC separations (Silica 60 F254-gel coated aluminium 
sheets; eluent: n-BuOH/CH3COOH/H2O (60:15:25, by 
vol.)).
Subfractions 4–5, 6–7 and 10–11 were further com-
bined together, according to their chromatographic 
(TLC) chemical pattern, and submitted to RP-HPLC on 
C18 µ-Bondapak column (300 mm × 7.8 mm, flow rate 
2.5 mL/min) with MeOH/H2O (40:60, v/v) to yield 
compounds 1 (5 mg) (tR= 8.27 min), 2 (4 mg) (tR= 23.17 
min), 3, 5, 6, 7 and 8 (3.5 mg) (tR= 29.24 min). The pu-
rity of all substances was between 95 and 98% based on 
1H NMR and HPLC analysis. Compound 4 was iden-
tified by comparison with a sample previously isolated 
(Innocenti et al., 2007).
1H NMR spectra were recorded at 303 K in Fourier 
transform mode at 300 MHz on a Varian Mercury VX 
instrument (Varian, Torino, Italy) equipped with a broad 
band 20-mm probe, using a spectral width of 20 p.p.m. 
and TMS as internal standard. HPLC-ESI-MS analysis was 
performed with a Thermo Finnigan LCQ Advantage ion 
trap mass spectrometer (Thermoquest, Milan, Italy). The 
ESI/MS source was set as follows: capillary temperature 
220 °C; spray voltage 4.5 kV; capillary voltage 10 V (posi-
tive ion mode) or –3 (negative ion mode); sheath gas flow 
rate 2 L/min; auxiliary gas flow rate 5 L/min. Spectra 
were detected in positive and negative ion mode (100–
1000 m/z, 0.5 scan/s). Components were separated on a 
Phenomenex Synergy RP80 A column (150 mm × 2 mm 
i.d., particle size 4 µm) protected with a Max-RP guard 
column (4 mm × 2 mm i.d., particle size 4 µm). Gradient 
elution: 100 % solvent A (H2O, 0.1 % HCOOH) to 60 % 
B (CH3CN, 0.1 % HCOOH) in 60 min, followed by re-
equilibration. Flow rate 0.2 mL/min.
Parasite cultures and drug susceptibility assay. P. fal-
ciparum cultures were carried out according to Trager and 
Jensen (1976) with minor modifications. Briefly, the CQ-
sensitive (D10) and CQ-resistant (W2) strains were main-
tained at 5 % hematocrit (human type A-positive red blood 
cells) in RPMI 1640 (EuroClone, Celbio) medium with the 
addition of 1 % AlbuMaxII (lipid-rich bovine serum albu-
min), 0.01 % hypoxantine, 20 mM Hepes, 2 mM glutamine. 
All the cultures were maintained at 37 °C in a standard gas 
mixture consisting of 1 % O2, 5 % CO2, 94 % N2. Com-
pounds were dissolved in either H2O or EtOH and then 
diluted with medium to achieve the required concentrations 
(final EtOH concentration <1 %, which is non-toxic to the 
parasite). Samples were placed in 96-well flat-bottom micro-
plates (COSTAR) after serial dilutions. Asynchronous cul-
tures with parasitaemia of 1–1.5 % and 1 % final hematocrit 
were aliquoted into the plates and incubated at 37 °C for 72 
h. Parasite growth was determined spectrophotometrically 
(OD650) by measuring the activity of the parasite lactate de-
hydrogenase (pLDH), according to a modified version of 
the method of Makler et al. (1993), in control and treated 
cultures. The antimalarial activity is expressed as IC50; each 
IC50 value is the mean ± S.D. of at least three separate ex-
periments performed in duplicate.
Determination of polyphenolic content. Total 
polyphenols were quantified colorimetrically by the Fo-
lin-Ciocalteau assay using gallic acid as reference stan-
dard (Vitalini et al., 2006). An aliquot of the samples was 
combined with 50 μL of Folin-Ciocalteau reagent; after 
3 min, 100 μL of a saturated sodium carbonate solution 
was added and then distilled water to reach a final vol-
ume of 2.5 mL. After 1 h of incubation in the dark at 
room temperature, the absorbance was read at 725 nm. 
Results were reported as mEq gallic acid.
DPPH scavenging test. The DPPH assay was per-
formed as previously described (Vitalini et al., 2006). 
Briefly, aliquots of the MeOH extract and pure com-
pounds, at five different concentrations (from 1 to 100 
mM), were added to a 15 μM EtOH solution of DPPH 
free radical. Absorbance at 517 nm was read after 15 
min of incubation in the dark. The IC50 was calculated 
with Prism® 4 (GraphPad Software Inc.). Each IC50 val-
ue is the mean ± S.D. of at least three separate experi-
ments performed in duplicate.
Total antioxidant capacity. Total antioxidant ca-
pacity (TAC) of the samples (at two concentrations: 1 
and 10 mM) was measured by a validated assay based 
on copper (II) reduction. (BIOXYTECH® AOP-490™, 
Oxis Research™, Portland, OR, USA) (Vitalini et al., 
2006). Results were reported as mEq uric acid.
Lipid peroxidation measurement. The lipid peroxi-
dation analysis was carried out according to a procedure 
previously reported (Vitalini et al., 2006). After isolation 
of human LDL by sequential ultracentrifugation, the 
total protein content was determined by the Bradford 
method. Subsequently, LDL fraction was diluted to 200 
µg protein/mL in 10 mM PBS. The content of TBARS 
was employed as a measure of lipid peroxidation. LDL 
fraction (500 μL), containing 100 μg of lipoprotein was 
treated by the addition of MeOH extract or pure com-
pounds at concentrations of 10 μM or 1 μM and then 
incubated for 15 min at 37 °C. Oxidation was triggered 
by the addition of CuSO4 (5 μM) and samples were in-
cubated at 37 °C for 3 h. Then, 300 μL of each sample 
was assayed by the addition of 600 μL of thiobarbituric 
acid reagent (0.375 g thiobarbituric acid, 2.08 mL 12 M 
HCl, 15 mL trichloroacetic acid 100% and distilled water 
to a final volume of 100 mL) and boiled for 15 min. Af-
ter centrifugation (10 000 × g for 10 min at 4 °C), super-
natants were analysed spectrophotometrically at 532 nm. 
Results are expressed as nmol of TBARS/mg of LDL 
protein.
Statistical analyses. Results are expressed as mean 
± S.D. of three independent determinations. All statis-
tical analyses were performed using the SPSS ver. 17.0 
software for Windows (SPSS, Chicago, IL, USA). Rela-
tionships between variables were examined by Spearman 
rank nonparametric correlation analysis. Multivariable lin-
ear regression was used to identify variables that influ-
ence the antiplasmodial activity, and conducted using a 
stepwise algorithm. 
RESULTS AND DISCUSSION
Phytochemical study
Table 1 shows chemical structures of ten compounds 
identified in the MeOH extract of the aerial parts of 
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A. millefolium. These compounds accounted for over 
90 % of the total area of the HPLC chromatogram 
(l = 250 nm). Three major peaks, detected at Rt = 6.22 
min, Rt = 21.05 min and Rt =22.91 min (1, 6 and 10 re-
spectively) and two minor peaks detected at Rt = 18.32 
min and at Rt = 19.44 min (4 and 5) were tentatively at-
tributed to five caffeic acid derivatives, whereas minor 
peaks 2, 3, 7, 8 and 9 were identified as flavonoid gly-
cosides on the basis of their UV spectra (not shown).
In accordance with the results from previous studies 
(Benedek et al., 2007; Innocenti et al., 2007), compounds 
1, 2, 3, 8 and 9 were identified as chlorogenic acid, ru-
tin, luteolin 7-O-glucoside, apigenin 7-O-glucoside, and 
luteolin 4′-O-glucoside, by comparison of their chroma-
tographic retention times and spectral data with those of 
pure commercially available compounds. 
The peaks corresponding to compounds 6, 7, and 10 
were isolated by semi-preparative HPLC and identified 
by NMR and HPLC-MS techniques.
The HPLC-DAD chromatogram (l = 250 nm, Fig. 1) 
showed the presence of two main peaks (Rt = 21.04 min 
and Rt = 21.36 min) corresponding to compounds 6 
and 10 characterized by identical UV spectra, with two 
main peaks at λmax 217 nm and 329 nm and shoulders 
at 239 nm and 300 nm (not shown), typical of the chlo-
rogenic acid chromophore. The presence of two chloro-
genic acid moieties in these compounds was confirmed 
by the HPLC-ESI-MS experiments that evidenced, in 
all cases, protonated pseudo-molecular ions at m/z 517 
[M+H+] (m 516 Da). The presence of a fragment ion 
at m/z 355 [M-caffeoyl+H]+, in the ESI-MS2 spectra of 
both compounds (not shown) indicated the structure of 
two isomeric dicaffeoyl derivatives of quinic acid never 
reported before in A. millefolium. Unequivocal confir-
mation of these structures was achieved by 1H NMR 
analyses. In accordance with the NMR data previously 
reported (Wang & Liu, 2007), these two major isomeric 
species were identified as 3,4-DCQA (compound 6) and 
3,5-DCQA (compound 10). 
Figure 1. HPLC profile (λ = 250 nm) of methanolic extract from A. millefolium 
1, Chlorogenic acid; 2, rutin; 3, luteolin 7-O-glucoside; 4, 1,3-dicaffeoylquinic acid; 5, 1,4-dicaffeoylquinic acid; 6, 3,4-dicaffeoylquinic acid; 
7, apigenin 4’-O-glucoside; 8, apigenin 7-O-glucoside; 9, luteolin 4’-O-glucoside; 10, 3,5-dicaffeoylquinic acid.
Figure 2. HPLC-ESI-MS and HPLC-ESI-
MS2 spectra of pseudo-molecular ion of 
compound 7 at [M+H]+ m/z 433 
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The identity of compound 7 was established on the 
basis of (i) its protonated [M+H]+ pseudo-molecular 
ion at m/z 433 and of a fragment at m/z 271 in the 
ESI-MS/MS spectrum (Fig. 2), and of (ii) its 1H and 
13C NMR data (dmso-d6, 300 MHz) that, according to the 
1H NMR data reported by Teng and colleagues (2002), 
were consistent with the structure of apigenin 4′-O-α-
glucopyranoside 7, an unusual derivative of apigenin, iden-
tified in this study for the first time in A. millefolium. 
The results of this part of the work have demon-
strated that the phytochemical profile of A. millefolium is 
mainly characterized by the presence of chlorogenic acid 
and its caffeoilquinic derivatives, besides luteolin, rutin, 
and apigenin flavonoid glycosides, some of which never 
reported before in this important plant species.
Antiplasmodial activity
The crude MeOH extract and its isolated components 
were tested for antiplasmodial activity in CQ-sensitive 
(D10) and CQ-resistant (W2) strains of P. falciparum, 
using CQ as a positive control. The results (Table 2) 
showed that the crude MeOH extract did not induce 
50 % mortality in the D10 strain of the parasite even at 
the highest concentration tested, but showed a measur-
able activity against the CQ-resistant W2 strain, with an 
IC50 value of 44.6 (± 8.8) μg/mL. 
Among the isolated compounds, apigenin 7-O-gluco-
side (8) and luteolin 7-O-glucoside (3) were the most 
active against both strains of P. falciparum (Table 2), in 
accordance with the findings from a previous study, in 
which both luteolin and apigenin inhibited the growth 
of other strains (3D7 and 7G8) of P. falciparum (Lehane 
Table 2. In vitro antiplasmodial activity against D10 and W2 
strains of P. falciparum
Compound D10IC50 (µg/mL)
W2
IC50 (µg/mL)
Chloroquine 0.010 ± 0.03 0.18 ± 0.07
Luteolin 6.1 ± 0.8 5.0 ± 1.1
Apigenin 25.4 ± 7.9 20.2 ± 6.4
1 >100 >100
2 68.5 ± 22.9 76.4 ± 7.7
3 26.2 ± 13.5 26.8 ± 3.6
4
>100a >100a
5
6
10
7 71.4 ± 11 58.7 ± 11.2
8 10.1 ± 1.3 6.1 ± 3.8
9 >100 >100
Methanolic extract >100 44.6 ± 8.8
aCompounds 4–6 and 10 in the same fraction tested before their iden-
tification. The results are expressed as IC50 ± S.D. of three different ex-
periments each performed in duplicate.
Table 3. Antioxidant activity of methanolic extract from A. millefolium and its isolated pure constituents in different model systems
Samples
DPPH (IC50) a
Antioxidant capacity
(mEq uric acid) b
TBARS
(nmol TBARS/mg LDL)c
1 µM 1 µM 10 µM 1 µM 10 µM
Ascorbic acid 1.31 ± 0.12 0.33 ± 0.02 0.36 ± 0.02 70.00 ± 2.10 4.62 ± 0.54
Chlorogenic acid 5.70 ± 0.24 0.41 ± 0.06 1.48 ± 0.15 11.03 ± 0.77 3.52 ± 0.49
Quercetin 4.37 ± 0.21 0.75 ± 0.06 2.17 ± 0.17 3.85 ± 0.50 0.75 ± 0.04
1 1.58 ± 0.11 0.30 ± 0.05 1.40 ± 0.38 71.49 ± 1.44 4.47 ± 0.62
2 1.50 ± 0.11 0.35 ± 0.07 1.84 ± 0.47 70.54 ± 1.09 4.94 ± 0.71
3 1.10 ± 0.09 0.11 ± 0.03 1.61 ± 0.52 10.04 ± 0.55 4.27 ± 0.46
4
3.78 ± 0.33d 0.34 ± 0.04d 1.56 ± 0.63d 69.59 ± 1.12d 3.04 ± 0.39d
5
6
10
7 3.83 ± 0.46 0.39 ± 0.05 1.72 ± 0.56 64.00 ± 0.96 3.66 ± 0.40
8 2.70 ± 0.17 0.21 ± 0.03 1.08 ± 0.34 10.79 ± 0.48 4.27 ± 0.62
9 2.68 ± 0.13 0.09 ± 0.01 0.20 ± 0.06 72.11 ± 1.56 12.84 ± 0.99
MeOH extract e 1.18 ± 0.10 0.17 ± 0.05 1.07 ± 0.29 50.40 ± 1.79 2.47 ± 0.51
aIC50 = concentration of sample needed to achieve 50 % scavenging of DPPH free radical; bmEq uric acid = unit of antioxidant capacity for copper 
reduction; cTBARS (thiobarbituric acid-reacting substances) in control samples were 71.14  (± 1.03) nmol/mg LDL; dCompounds 4–6 and 10 in the 
same fraction tested before their identification; eThe concentration of MeOH extract was 184 mg/ml; Ascorbic acid, chlorogenic acid and quercetin 
are reference compounds. Experiments were performed in triplicate; results are mean ± S.D.
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& Saliba, 2008). These results suggest that the presence 
of the 7-O-glycoside in the flavonoid moiety does not 
inhibit their antiplasmodial activity or that the aglycone 
becomes active after enzymatic hydrolysis of the glyco-
side bond.
Apigenin 4′-O-glucoside (7) and rutin (2) showed 
moderate activity against the both strains, while the oth-
er components were completely inactive. 
Antioxidant activity
The antioxidant activity of the MeOH extract and its 
components were evaluated using different in vitro as-
says. The radical scavenging activity was evaluated by the 
DPPH test, the TAC by the copper reducing power as-
say and the anti-lipoperoxidant activity in LDL against 
Cu2+ insult by the TBARS assay. Ascorbic acid, chloro-
genic acid and quercetin were used as reference com-
pounds and the results are summarized in Table 3. No-
ticeably, for TAC, ascorbic acid did not exhibit signifi-
cant differences between 10–5 and 10–6 concentrations. 
We speculatively attribute this to a plateau effect at low 
concentrations associated with the method.
The MeOH extract, whose polyphenolic content deter-
mined by the Folin-Ciocalteau method was 281.7 mg/g, 
exhibited significant activities in all the models used, com-
parable to those of the control antioxidants. Concerning 
pure compounds, on the whole they displayed a rather 
high degree of activities. In particular rutin (2), chlorogen-
ic acid (1) and its derivatives 4, 5, 6 and 10 (in the same 
fraction not further separated because of its low amount), 
and the apigenin derivatives 7 and 8 showed values similar 
to those of the reference standards, both in terms of scav-
enging ability (DPPH) and TAC. 
The results from the TBARS assay showed that, 
among the compounds isolated, only 3 and 8 displayed 
an activity somewhat comparable to that of chlorogenic 
acid, even at the lowest concentration tested (1 µM); all 
the other compounds were able to inhibit the TBARS 
formation only at the highest concentration tested 
(10 µM). 
Statistics
The correlation and multivariate regression analyses 
carried out on the antiplasmodial and antioxidant data of 
compounds 1–10 at 1 µM concentration evidenced a sig-
nificant correlation (Fig. 3) between their activity against 
TBARS formation and growth inhibition of the CQ re-
sistant strain of P. falciparum (RSpearman = 0.786, P < 0.005; 
regression: betaTBARS = 0.776, P < 0.01), suggesting that 
the antilipoperoxidant compounds were the same as 
those responsible for the inhibition of the parasite. As 
shown in Fig. 3, this correlation was mainly due to com-
pounds 3 and 8 in both tests suggesting luteolin 7-O-glu-
coside (3) and apigenin 7-O-glucoside (8) as the compo-
nents putatively responsible for both the antilipoperoxi-
dant and antiplasmodial activities of the MeOH extract. 
To some extent, these results are in accordance with 
those of other studies (Kirmizibekmez et al., 2004; Tas-
demir, 2006; Tasdemir et al., 2006) that reported luteolin 
7-O-glucoside (3) as an inhibitor of P. falciparum growth. 
Most importantly, they provided evidence that inhibition 
of enzymes involved in the plasmodial type II fatty acid 
biosynthesis is a potential biochemical target for the in 
vitro inhibitory activity of flavonoids against the parasite. 
It is interesting to observe that the isomeric forms of 3 
and 8, in which glycosylation occurs at the 4′-O-position 
(compounds 7 and 9), are much less active in both tests, 
confirming that the availability of ring B phenol groups 
is an important factor for the definition of the structure–
activity relationships of these compounds.
CONCLUSIONS
The results of this work contribute to the definition 
of the phytochemical profile of the MeOH extract of A. 
millefolium. Evaluation of the antioxidant and antiplasmo-
dial activities of the isolated pure compounds suggests 
that flavonoid glycosides 3 and 8 are the main compo-
nents responsible for both investigated activities and, to 
the best of our knowledge, antiplasmodial activity of api-
genin 7-O-glucoside is reported here for the first time, 
as well as the correlation between the antioxidant pow-
er and the antiplasmodial activity of the isolated com-
pounds.
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